Skip to content
The Nexus
BUSINESSAug 4 · 21:19 UTCWTOP DCWTOP Staff

Cumberland: Q2 Earnings Snapshot

Cumberland Pharmaceuticals Inc. reported a second-quarter loss of $4.1 million, or 27 cents per share, with adjusted losses at 20 cents per share and revenue of $166,000.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting